Mark A. A. Claassen
- Hepatology top 5%
- Epidemiology
- Immunology top 10%
- Infectious Diseases
- Rheumatology
- Co-authors
- André BoonstraHarry L.A. JanssenRobert J. de KnegtHugo W. TilanusZwier M. A. GroothuisminkGertine W. van OordMichelle SpaanBart Rijnders
- Topics
- Hepatitis C virus research (18 papers)Hepatitis B Virus Studies (10 papers)Liver Disease Diagnosis and Treatment (8 papers)
- Cited by
- HepatologyImmunologyEpidemiology
- Partner nations
- NetherlandsCanadaGermany
In The Last Decade
Mark A. A. Claassen
28 papers receiving 483 citations
Peers
Comparison fields: 5 of 59
- Hepatology 249
- Epidemiology 233
- Immunology 224
- Infectious Diseases 92
- Rheumatology 37
Countries citing papers authored by Mark A. A. Claassen
This map shows the geographic impact of Mark A. A. Claassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. A. Claassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. A. Claassen more than expected).
Fields of papers citing papers by Mark A. A. Claassen
This network shows the impact of papers produced by Mark A. A. Claassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. A. Claassen. The network helps show where Mark A. A. Claassen may publish in the future.
Co-authorship network of co-authors of Mark A. A. Claassen
This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. A. Claassen. A scholar is included among the top collaborators of Mark A. A. Claassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. A. Claassen. Mark A. A. Claassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 4 | |
| 10 | 9 | |
| 11 | 3 | |
| 12 | 34 | |
| 13 | 52 | |
| 14 | 16 | |
| 15 | 22 | |
| 16 | 11 | |
| 17 | 4 | |
| 18 | 116 | |
| 19 | 42 | |
| 20 | 22 |
About Mark A. A. Claassen
Mark A. A. Claassen is a scholar working on Hepatology, Virology and Applied Microbiology and Biotechnology, having authored 30 papers that have together received 488 indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). The work is most often cited by research in Hepatology (249 citations), Immunology (224 citations) and Epidemiology (233 citations). Mark A. A. Claassen has collaborated with scholars based in Netherlands, Canada and Germany. Frequent co-authors include André Boonstra, Harry L.A. Janssen, Robert J. de Knegt, Hugo W. Tilanus, Zwier M. A. Groothuismink, Gertine W. van Oord, Michelle Spaan, Bart Rijnders, Sebastiaan Hullegie and Kim Kreefft. Their work appears in journals such as PLoS ONE, Journal of Virology and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.